New horizons in hepatitis C antiviral therapy with direct-acting antivirals, Hepatology, vol.57, issue.Suppl S1, 2013. ,
DOI : 10.1002/hep.26371
Increasing prevalence of HCC and cirrhosis in patients with chronic hepatitis C virus infection, Gastroenterology, vol.140, p.11821188, 2011. ,
Telaprevir and peginterferon with or without ribavirin for chronic HCV infection, N. Engl. J. Med, vol.360, p.18391850, 2009. ,
Telaprevir with peginterferon and ribavirin for chronic HCV genotype 1 infection, N. Engl. J. Med, vol.360, p.18271838, 2009. ,
Boceprevir for Untreated Chronic HCV Genotype 1 Infection, New England Journal of Medicine, vol.364, issue.13, 2011. ,
DOI : 10.1056/NEJMoa1010494
URL : https://hal.archives-ouvertes.fr/hal-00867494
Boceprevir for previously treated chronic HCV genotype 1 infection, N. Engl. J. Med, vol.364, p.12071217, 2011. ,
Telaprevir for previously treated chronic HCV infection, N. Engl. J. Med, vol.362, p.12921303, 2010. ,
Histologic observations in human hepatitis non-A, non-B. Hepatology, 1982. ,
Association of hepatitis C virus in human sera with beta-lipoprotein, Med. Microbiol. Immunol, pp.181-293300, 1992. ,
Density heterogeneities of hepatitis C virus in human sera due to the binding of beta-lipoproteins and immunoglobulins, Med. Microbiol. Immunol, vol.182, p.329334, 1993. ,
Preferential association of Hepatitis C virus with apolipoprotein B48-containing lipoproteins, J. Gen. Virol, vol.87, p.29832991, 2006. ,
URL : https://hal.archives-ouvertes.fr/inserm-00139590
Intravascular transfer contributes to postprandial increase in numbers of very-low-density hepatitis C virus particles, Gastroenterology, vol.139, p.17741783, 2010. ,
High plasma level of nucleocapsidfree envelope glycoprotein-positive lipoproteins in hepatitis C patients, Hepatology, vol.56, p.3948, 2012. ,
URL : https://hal.archives-ouvertes.fr/hal-00683361
Identification of a Residue in Hepatitis C Virus E2 Glycoprotein That Determines Scavenger Receptor BI and CD81 Receptor Dependency and Sensitivity to Neutralizing Antibodies, Journal of Virology, vol.82, issue.24, p.1202012029, 2008. ,
DOI : 10.1128/JVI.01569-08
Hypervariable Region 1 Differentially Impacts Viability of Hepatitis C Virus Strains of Genotypes 1 to 6 and Impairs Virus Neutralization, Journal of Virology, vol.85, issue.5, p.22242234, 2011. ,
DOI : 10.1128/JVI.01594-10
Viral entry and escape from antibody-mediated neutralization influence hepatitis C virus reinfection in liver transplantation, The Journal of Experimental Medicine, vol.119, issue.9, 2010. ,
DOI : 10.1073/pnas.0503596102
Mutations That Alter Use of Hepatitis C Virus Cell Entry Factors Mediate Escape From Neutralizing Antibodies, Gastroenterology, vol.143, issue.1, p.223233, 2012. ,
DOI : 10.1053/j.gastro.2012.04.006
URL : https://hal.archives-ouvertes.fr/inserm-00701511
PAT proteins, an ancient family of lipid droplet proteins that regulate cellular lipid stores, Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, vol.1791, issue.6, 1791. ,
DOI : 10.1016/j.bbalip.2009.04.002
Thematic review series: Adipocyte Biology. The perilipin family of structural lipid droplet proteins: stabilization of lipid droplets and control of lipolysis, The Journal of Lipid Research, vol.48, issue.12, pp.48-25472559, 2007. ,
DOI : 10.1194/jlr.R700014-JLR200
The metabolism of triglyceride-rich lipoproteins revisited: New players, new insight, Atherosclerosis, vol.211, issue.1, p.18, 2010. ,
DOI : 10.1016/j.atherosclerosis.2009.12.027
Molecular processes that handleand mishandledietary lipids, J. Clin. Invest, vol.118, p.32473259, 2008. ,
Lotteau, V. Characterization of low-and very-low-density hepatitis C virus RNA-containing particles, J. Virol, pp.76-69196928, 2002. ,
Association between Hepatitis C Virus and Very-Low-Density Lipoprotein (VLDL)/LDL Analyzed in Iodixanol Density Gradients, Journal of Virology, vol.80, issue.5, p.24182428, 2006. ,
DOI : 10.1128/JVI.80.5.2418-2428.2006
Hepatocyte steatosis is a cytopathic effect of hepatitis C virus genotype 3, Journal of Hepatology, vol.33, issue.1, p.106115, 2000. ,
DOI : 10.1016/S0168-8278(00)80166-X
Hepatitis C virus induced hypobetalipoproteinemia: A possible mechanism for steatosis in chronic hepatitis C, J. Hepatol, vol.34, p.428434, 2001. ,
Expression profile of lipid metabolism-associated genes in hepatitis C virus-infected human liver, Hepatology Research, vol.100, issue.s2, pp.40-923929, 2010. ,
DOI : 10.1111/j.1872-034X.2010.00700.x
Changes in the expression of cholesterol metabolism-associated genes in HCV-infected liver: A novel target for therapy?, Int. J. Mol. Med, vol.24, p.825828, 2009. ,
Genomic analysis of the host response to hepatitis C virus infection, Proc. Natl. Acad. Sci, p.1566915674, 2002. ,
Altered expression patterns of lipid metabolism genes in an animal model of HCV core-related, nonobese, modest hepatic steatosis, BMC Genomics, vol.9, issue.1, p.109, 2008. ,
DOI : 10.1186/1471-2164-9-109
Hepatitis C Virus Proteins Induce Lipogenesis and Defective Triglyceride Secretion in Transgenic Mice, Journal of Biological Chemistry, vol.284, issue.48, p.3346633474, 2009. ,
DOI : 10.1074/jbc.M109.019810
URL : https://hal.archives-ouvertes.fr/inserm-00441475
Activation of sterol regulatory element-binding protein 1c and fatty acid synthase transcription by hepatitis C virus non-structural protein 2, Journal of General Virology, vol.89, issue.5, p.12251230, 2008. ,
DOI : 10.1099/vir.0.83491-0
Hepatitis C Virus Nonstructural 4B Protein Modulates Sterol Regulatory Element-binding Protein Signaling via the AKT Pathway, Journal of Biological Chemistry, vol.284, issue.14, p.92379246, 2009. ,
DOI : 10.1074/jbc.M808773200
Hepatitis C Virus Induces Proteolytic Cleavage of Sterol Regulatory Element Binding Proteins and Stimulates Their Phosphorylation via Oxidative Stress, Journal of Virology, vol.81, issue.15, pp.81-81228130, 2007. ,
DOI : 10.1128/JVI.00125-07
Investigation of the role of SREBP-1c in the pathogenesis of HCV-related steatosis, Journal of Hepatology, vol.49, issue.6, pp.49-10461054, 2008. ,
DOI : 10.1016/j.jhep.2008.06.022
Elevated lipogenesis and diminished cholesterol synthesis in patients with hepatitis C viral infection compared to healthy humans, Hepatology, vol.10, issue.5, p.16971704, 2012. ,
DOI : 10.1002/hep.25990
Hepatic Steatosis in Hepatitis C Virus Genotype 3 Infection: Does It Correlate with Body Mass Index, Fibrosis, and HCV Risk Factors?, Digestive Diseases and Sciences, vol.49, issue.1, pp.49-2529, 2004. ,
DOI : 10.1023/B:DDAS.0000011597.92851.56
Prevalence of liver steatosis in patients with chronic hepatitis B: a study of associated factors and of relationship with fibrosis, European Journal of Gastroenterology & Hepatology, vol.18, issue.3, p.233237, 2006. ,
DOI : 10.1097/00042737-200603000-00002
Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity, Hepatology, vol.33, issue.6, p.13581364, 2001. ,
DOI : 10.1053/jhep.2001.24432
Serum HCV RNA levels correlate with histological liver damage and concur with steatosis in progression of chronic hepatitis C, Dig. Dis. Sci, pp.46-16771683, 2001. ,
Hepatocellular fat accumulation and low serum cholesterol in patients infected with HCV-3a, The American Journal of Gastroenterology, vol.28, issue.11, pp.97-28802885, 2002. ,
DOI : 10.1016/S0140-6736(95)91685-7
Metabolic and cardiovascular risk profiles and hepatitis C virus infection in rural Egypt, Gut, vol.56, issue.8, 2007. ,
DOI : 10.1136/gut.2006.091983
Hepatitis C virus selectively perturbs the distal cholesterol synthesis pathway in a genotype-specific manner, Hepatology, vol.100, issue.1, p.4956, 2012. ,
DOI : 10.1002/hep.25631
Hepatitis C Virus Nonstructural Proteins Inhibit Apolipoprotein B100 Secretion, Journal of Biological Chemistry, vol.280, issue.48, p.3980239808, 2005. ,
DOI : 10.1074/jbc.M510391200
Liver Microsomal Triglyceride Transfer Protein Is Involved in Hepatitis C Liver Steatosis, Gastroenterology, vol.130, issue.6, p.16611669, 2006. ,
DOI : 10.1053/j.gastro.2006.02.035
Ferritin Heavy Chain Is the Host Factor Responsible for HCV-Induced Inhibition of apoB-100 Production and Is Required for Efficient Viral Infection, Journal of Proteome Research, vol.11, issue.5, p.27862797, 2012. ,
DOI : 10.1021/pr201128s
URL : https://hal.archives-ouvertes.fr/pasteur-00957464
Metabolic Disorders and Steatosis in Patients with Chronic Hepatitis C: Metabolic Strategies for Antiviral Treatments, International Journal of Hepatology, vol.6, issue.5, 2012. ,
DOI : 10.1159/000322219
Associations between hepatitis C viremia and low serum triglyceride and cholesterol levels: A community-based study, Journal of Hepatology, vol.49, issue.1, pp.49-916, 2008. ,
DOI : 10.1016/j.jhep.2008.03.016
Decreases in the Serum VLDL-TG/Non-VLDL-TG Ratio from Early Stages of Chronic Hepatitis C: Alterations in TG-Rich Lipoprotein Levels, PLoS ONE, vol.35, issue.2, 2011. ,
DOI : 10.1371/journal.pone.0017309.t001
Biochemical and morphological properties of hepatitis C virus particles and determination of their lipidome, J. Biol. Chem, vol.286, p.30183032, 2011. ,
Production and characterization of HCV particles from serum-free culture, Vaccine, vol.29, p.48214828, 2011. ,
The C-terminal alpha-helix domain of apolipoprotein E is required for interaction with nonstructural protein 5A and assembly of hepatitis C virus, J. Virol, vol.84, p.1153211541, 2010. ,
Reconstitution of the Entire Hepatitis C Virus Life Cycle in Nonhepatic Cells, Journal of Virology, vol.86, issue.21, p.1191911925, 2012. ,
DOI : 10.1128/JVI.01066-12
URL : https://hal.archives-ouvertes.fr/inserm-00734834
Infectivity of Hepatitis C Virus Is Influenced by Association with Apolipoprotein E Isoforms, Journal of Virology, vol.84, issue.22, p.1204812057, 2010. ,
DOI : 10.1128/JVI.01063-10
Mouse Hepatic Cells Support Assembly of Infectious Hepatitis C Virus Particles, Gastroenterology, vol.141, issue.3, p.10571066, 2011. ,
DOI : 10.1053/j.gastro.2011.06.010
Apolipoprotein epsilon3 allele is associated with persistent hepatitis C virus infection, Gut, vol.55, 2006. ,
Apolipoprotein E genotype and hepatitis C, HIV and herpes simplex disease risk: a literature review, Lipids in Health and Disease, vol.9, issue.1, p.8, 2010. ,
DOI : 10.1186/1476-511X-9-8
Apolipoprotein E-epsilon 4 protects against severe liver disease caused by hepatitis C virus, Hepatology, vol.36, p.456463, 2002. ,
Association of genetic polymorphism of low-density lipoprotein receptor with chronic viral hepatitis C infection in Han Chinese, Journal of Medical Virology, vol.47, issue.10, pp.78-12891295, 2006. ,
DOI : 10.1002/jmv.20693
Very low density lipoprotein and low density lipoprotein isolated from patients with hepatitis C infection induce altered cellular lipid metabolism, Journal of Medical Virology, vol.39, issue.3, pp.79-254258, 2007. ,
DOI : 10.1002/jmv.20793
Hepatitis C virus production requires apolipoprotein A-I and affects its association with nascent low-density lipoproteins, Gut, vol.60, issue.3, p.378386, 2011. ,
DOI : 10.1136/gut.2010.211292
URL : https://hal.archives-ouvertes.fr/pasteur-00980167
Expression of apolipoprotein C-IV is regulated by Ku antigen/peroxisome proliferator-activated receptor gamma complex and correlates with liver steatosis, J. Hepatol, pp.49-787798, 2008. ,
Serum apolipoprotein C-III is independently associated with chronic hepatitis C infection and advanced fibrosis, Hepatology International, vol.118, issue.2, p.475481 ,
DOI : 10.1007/s12072-011-9291-x
Effect of treatment with peginterferon or interferon alfa-2b and ribavirin on steatosis in patients infected with hepatitis C, Hepatology, vol.38, p.7585, 2003. ,
Impact of hepatic steatosis on viral kinetics and treatment outcome during antiviral treatment of chronic HCV infection, Journal of Viral Hepatitis, vol.28, issue.3, p.2935, 2007. ,
DOI : 10.1136/gut.51.1.89
Peginterferon alfa-2b plus ribavirin for treatment of chronic hepatitis C in previously untreated patients infected with HCV genotypes 2 or 3, J. Hepatol, pp.40-993999, 2004. ,
Hepatitis C virus infection and its clearance alter circulating lipids: Implications for long-term follow-up, Hepatology, vol.232, issue.4, p.10301037, 2009. ,
DOI : 10.1002/hep.23219
Correlation between beta-lipoprotein levels and outcome of hepatitis C treatment, Hepatology, vol.98, issue.2, p.335340, 2006. ,
DOI : 10.1002/hep.21261
Associations between serum lipids and hepatitis C antiviral treatment efficacy, Hepatology, vol.45, issue.3, p.854863, 2010. ,
DOI : 10.1002/hep.23796
Florio, A. Chronic HCV infection is a risk of atherosclerosis. Role of HCV and HCV-related steatosis, Atherosclerosis, vol.221, p.496502, 2012. ,
Predictive factors of early and sustained responses to peginterferon plus ribavirin combination therapy in Japanese patients infected with hepatitis C virus genotype 1b: Amino acid substitutions in the core region and low-density lipoprotein cholesterol levels, Journal of Hepatology, vol.46, issue.3, pp.46-403410, 2007. ,
DOI : 10.1016/j.jhep.2006.09.019
Apolipoprotein-E and hepatitis C lipoviral particles in genotype 1 infection: Evidence for an association with interferon sensitivity, Journal of Hepatology, vol.57, issue.1, p.3238, 2012. ,
DOI : 10.1016/j.jhep.2012.02.017
Insulin resistance and low-density apolipoprotein B-associated lipoviral particles in hepatitis C virus genotype 1 infection, Gut, vol.60, issue.5, p.680687, 2011. ,
DOI : 10.1136/gut.2010.222133
Interferon-lambda genotype and low serum low-density lipoprotein cholesterol levels in patients with chronic hepatitis C infection, Hepatology, vol.100, issue.Suppl., 2010. ,
DOI : 10.1002/hep.23592
Treatment of insulin resistance with metformin in naive genotype 1 chronic hepatitis C patients receiving peginterferon alfa-2a plus ribavirin, Hepatology, vol.50, p.17021708, 2009. ,
Add-on therapy of pitavastatin and eicosapentaenoic acid improves outcome of peginterferon plus ribavirin treatment for chronic hepatitis C, Journal of Medical Virology, vol.4, issue.2, p.250260, 2013. ,
DOI : 10.1002/jmv.23464
Pioglitazone Decreases Hepatitis C Viral Load in Overweight, Treatment Na??ve, Genotype 4 Infected-Patients: A Pilot Study, PLoS ONE, vol.461, issue.6, 2012. ,
DOI : 10.1371/journal.pone.0031516.s002
Serum cholesterol and statin use predict virological response to peginterferon and ribavirin therapy, Hepatology, vol.52, p.864874, 2010. ,
Combination of fluvastatin with pegylated interferon/ribavirin therapy reduces viral relapse in chronic hepatitis C infected with HCV genotype 1b, Journal of Gastroenterology and Hepatology, vol.465, issue.1, p.5156, 2013. ,
DOI : 10.1111/j.1440-1746.2012.07267.x
Statin Therapy Improves Sustained Virologic Response Among Diabetic Patients With Chronic Hepatitis C, Gastroenterology, vol.140, issue.1, p.144152, 2011. ,
DOI : 10.1053/j.gastro.2010.08.055
Disruption of hepatitis C virus RNA replication through inhibition of host protein geranylgeranylation, Proc. Natl. Acad. Sci. USA 2003, p.1586515870 ,
DOI : 10.1073/pnas.2237238100
Fluvastatin Inhibits Hepatitis C Replication in Humans, The American Journal of Gastroenterology, vol.30, issue.2, p.13831389, 2008. ,
DOI : 10.1002/hep.21554
Do statins reduce hepatitis C RNA titers during routine clinical use?, World Journal of Gastroenterology, vol.15, issue.40, p.50205027, 2009. ,
DOI : 10.3748/wjg.15.5020
Does fluvastatin favour HCV replication in vivo? A pilot study on HIV-HCV coinfected patients, J. Viral. Hepatitis, vol.16, p.479484, 2009. ,
Atorvastatin does not exhibit antiviral activity against HCV at conventional doses: A pilot clinical trial, Hepatology, vol.45, p.895898, 2007. ,
Peginterferon alfa-2b or alfa-2a with ribavirin for treatment of hepatitis C infection, N. Engl. J. Med, pp.361-580593, 2009. ,
Fluvastatin as an adjuvant to pegylated interferon and ribavirin in HIV/hepatitis C virus genotype 1 co-infected patients: an open-label randomized controlled study, Journal of Antimicrobial Chemotherapy, vol.65, issue.4, pp.65-735740, 2010. ,
DOI : 10.1093/jac/dkq002
An Open Pilot Study Exploring the Efficacy of Fluvastatin, Pegylated Interferon and Ribavirin in Patients with Hepatitis C Virus Genotype 1b in High Viral Loads, Intervirology, vol.52, issue.1, p.4348, 2009. ,
DOI : 10.1159/000213504
Mipomersen, an apolipoprotein B synthesis inhibitor, for lowering of LDL cholesterol concentrations in patients with homozygous familial hypercholesterolaemia: a randomised, double-blind, placebo-controlled trial, The Lancet, vol.375, issue.9719, p.9981006, 2010. ,
DOI : 10.1016/S0140-6736(10)60284-X
miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting, Cell Metabolism, vol.3, issue.2, p.8798, 2006. ,
DOI : 10.1016/j.cmet.2006.01.005
Therapeutic Silencing of MicroRNA-122 in Primates with Chronic Hepatitis C Virus Infection, Science, vol.327, issue.5962, 2010. ,
DOI : 10.1126/science.1178178
Naringenin inhibits the assembly and long-term production of infectious hepatitis C virus particles through a PPAR-mediated mechanism, Journal of Hepatology, vol.55, issue.5, pp.55-963971, 2011. ,
DOI : 10.1016/j.jhep.2011.02.011
Apolipoprotein B-dependent hepatitis C virus secretion is inhibited by the grapefruit flavonoid naringenin, Hepatology, vol.7, issue.pt 9, pp.47-14371445, 2008. ,
DOI : 10.1002/hep.22197
The green tea polyphenol, epigallocatechin-3-gallate, inhibits hepatitis C virus entry, Hepatology, vol.76, issue.6, 2011. ,
DOI : 10.1002/hep.24610
(???)-Epigallocatechin-3-gallate is a new inhibitor of hepatitis C virus entry, Hepatology, vol.436, issue.Suppl 1, p.720729, 2012. ,
DOI : 10.1002/hep.24803
Green Tea Phenolic Epicatechins Inhibit Hepatitis C Virus Replication via Cycloxygenase-2 and Attenuate Virus-Induced Inflammation, PLoS ONE, vol.55, issue.1, p.54466, 2013. ,
DOI : 10.1371/journal.pone.0054466.s001
Hepatitis C virus particle detected by immunoelectron microscopic study, Journal of General Virology, vol.75, issue.7, pp.75-17551760, 1994. ,
DOI : 10.1099/0022-1317-75-7-1755
Hepatitis C virus: Buoyant density if the factor VIII-derived isolate in sucrose, Journal of Medical Virology, vol.65, issue.3, 1991. ,
DOI : 10.1002/jmv.1890340315
Posttransfusion non-A, non-B hepatitis in chimpanzees. Physicochemical evidence that the tubule-forming agent is a small, enveloped virus, Gastroenterology, vol.88, p.773779, 1985. ,
Determining the Size of Non-A, Non-B Hepatitis Virus by Filtration, Journal of Infectious Diseases, vol.156, issue.4, p.636640, 1987. ,
DOI : 10.1093/infdis/156.4.636
Density analysis of hepatitis C virus particle population in the circulation of infected hosts: implications for virus neutralization or persistence, Journal of Hepatology, vol.22, issue.4, p.440448, 1995. ,
DOI : 10.1016/0168-8278(95)80107-3
Hepatitis C virus particles of different density in the blood of chronically infected immunocompetent and immunodeficient patients: Implications for virus clearance by antibody, Journal of Medical Virology, vol.25, issue.3, pp.68-335342, 2002. ,
DOI : 10.1002/jmv.10208
Characterization of hepatitis C RNA-containing particles from human liver by density and size, Journal of General Virology, vol.89, issue.10, p.25072517, 2008. ,
DOI : 10.1099/vir.0.2008/000083-0
Equilibrium centrifugation studies of hepatitis C virus: Evidence for circulating immune complexes, J. Virol, vol.67, 1993. ,
Complete Replication of Hepatitis C Virus in Cell Culture, Science, vol.309, issue.5734, p.623626, 2005. ,
DOI : 10.1126/science.1114016
Production of infectious hepatitis C virus in tissue culture from a cloned viral genome, Nature Medicine, vol.37, issue.7, p.791796, 2005. ,
DOI : 10.1002/jmv.10297
Robust hepatitis C virus infection in vitro, Proc. Natl. Acad. Sci. USA 2005, p.92949299 ,
Differential Biophysical Properties of Infectious Intracellular and Secreted Hepatitis C Virus Particles, Journal of Virology, vol.80, issue.22, p.1107411081, 2006. ,
DOI : 10.1128/JVI.01150-06
Human Apolipoprotein E Is Required for Infectivity and Production of Hepatitis C Virus in Cell Culture, Journal of Virology, vol.81, issue.24, pp.81-1378313793, 2007. ,
DOI : 10.1128/JVI.01091-07
Cellular Determinants of Hepatitis C Virus Assembly, Maturation, Degradation, and Secretion, Journal of Virology, vol.82, issue.5, p.21202129, 2008. ,
DOI : 10.1128/JVI.02053-07
Huh-7 or HepG2 cells: which is the better model for studying human apolipoprotein-B100 assembly and secretion?, The Journal of Lipid Research, vol.52, issue.1, p.152158, 2011. ,
DOI : 10.1194/jlr.D008888
Characterization of infectious hepatitis C virus from liver-derived cell lines, Biochem. Biophys. Res. Commun, vol.377, p.747751, 2008. ,
Ultrastructural and Biophysical Characterization of Hepatitis C Virus Particles Produced in Cell Culture, Journal of Virology, vol.84, issue.21, 2010. ,
DOI : 10.1128/JVI.00526-10
Cell culture-grown hepatitis C virus is infectious in vivo and can be recultured in vitro, Proc. Natl. Acad. Sci, p.38053809, 2006. ,
DOI : 10.1073/pnas.0511218103
Production of infectious hepatitis C virus in primary cultures of human adult hepatocytes, Gastroenterology, vol.139, p.13551364, 2010. ,
VLDL-producing and HCV-replicating HepG2 cells secrete no more LVP than VLDL-deficient Huh7.5 cells, J. Virol, vol.87, p.50655080, 2013. ,
DOI : 10.1128/jvi.01405-12
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3624324
Critical Role of Virion-Associated Cholesterol and Sphingolipid in Hepatitis C Virus Infection, Journal of Virology, vol.82, issue.12, p.57155724, 2008. ,
DOI : 10.1128/JVI.02530-07
Secretion of Hepatitis C Virus Envelope Glycoproteins Depends on Assembly of Apolipoprotein B Positive Lipoproteins, PLoS ONE, vol.15, issue.1, p.4233, 2009. ,
DOI : 10.1371/journal.pone.0004233.g010
Apolipoprotein C1 Association with Hepatitis C Virus, Journal of Virology, vol.82, issue.19, p.96479656, 2008. ,
DOI : 10.1128/JVI.00914-08
Apolipoprotein E interacts with hepatitis C virus nonstructural protein 5A and determines assembly of infectious particles, Hepatology, vol.47, issue.2 Suppl 1, p.4353, 2010. ,
DOI : 10.1002/hep.23278
URL : https://hal.archives-ouvertes.fr/inserm-00705655
Apolipoprotein E on hepatitis C virion facilitates infection through interaction with low-density lipoprotein receptor, Virology, vol.394, issue.1, p.99108, 2009. ,
DOI : 10.1016/j.virol.2009.08.037
Differential Metabolism of Human VLDL According to Content of ApoE and ApoC-III, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.21, issue.9, p.14941500, 2001. ,
DOI : 10.1161/hq0901.094489
The Exchangeable Apolipoprotein ApoC-I Promotes Membrane Fusion of Hepatitis C Virus, Journal of Biological Chemistry, vol.282, issue.44, p.3235732369, 2007. ,
DOI : 10.1074/jbc.M705358200
URL : https://hal.archives-ouvertes.fr/hal-00315131
Hepatitis C virus E1 envelope glycoprotein interacts with apolipoproteins in facilitating entry into hepatocytes, Hepatology, vol.136, issue.4, p.11491156, 2011. ,
DOI : 10.1002/hep.24523
Forns, X. Interplay between basic residues of hepatitis C virus glycoprotein E2 with viral receptors, neutralizing antibodies and lipoproteins, PLoS One, 2012. ,
Persistent Hepatitis C Virus Infection In Vitro: Coevolution of Virus and Host, Journal of Virology, vol.80, issue.22, p.1108211093, 2006. ,
DOI : 10.1128/JVI.01307-06
The rate of hepatitis C virus infection initiation in vitro is directly related to particle density, Virology, vol.407, issue.1, p.110119, 2010. ,
DOI : 10.1016/j.virol.2010.07.026
Hepatitis C virus and other Flaviviridae viruses enter cells via low density lipoprotein receptor, Proc. Natl. Acad. Sci. USA 1999, p.1276612771 ,
DOI : 10.1073/pnas.96.22.12766
Role of low-density lipoprotein receptor in the hepatitis C virus life cycle, Hepatology, vol.55, p.9981007, 2012. ,
Deletion of the Basement Membrane Heparan Sulfate Proteoglycan Type XVIII Collagen Causes Hypertriglyceridemia in Mice and Humans, PLoS ONE, vol.284, issue.11, p.13919, 2010. ,
DOI : 10.1371/journal.pone.0013919.s001
Lipoprotein Lipase Bound to Apolipoprotein B Lipoproteins Accelerates Clearance of Postprandial Lipoproteins in Humans, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.26, issue.4, p.891896, 2006. ,
DOI : 10.1161/01.ATV.0000203512.01007.3d
Hepatitis C Virus Entry, Curr. Top. Microbiol. Immunol, vol.369, issue.87112, 2013. ,
DOI : 10.1007/978-3-642-27340-7_4
URL : https://hal.archives-ouvertes.fr/inserm-00850902
EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy, Nature Medicine, vol.31, issue.5, p.589595, 2011. ,
DOI : 10.1016/0022-1759(83)90303-4
URL : https://hal.archives-ouvertes.fr/inserm-00705829
HRas Signal Transduction Promotes Hepatitis C Virus Cell Entry by Triggering Assembly of the Host Tetraspanin Receptor Complex, Cell Host & Microbe, vol.13, issue.3, p.302313, 2013. ,
DOI : 10.1016/j.chom.2013.02.006
Lipoproteins and the liver sieve: The role of the fenestrated sinusoidal endothelium in lipoprotein metabolism, Atherosclerosis, and cirrhosis, Hepatology, vol.21, p.863874, 1995. ,
Role of the low density lipoprotein (LDL) receptor pathway in the metabolism of chylomicron remnants. A quantitative study in knockout mice lacking the LDL receptor, apolipoprotein E, or both, J. Biol. Chem, pp.271-2242222427, 1996. ,
Inducible inactivation of hepatic LRP gene by cre-mediated recombination confirms role of LRP in clearance of chylomicron remnants., Journal of Clinical Investigation, vol.101, issue.3, p.689695, 1998. ,
DOI : 10.1172/JCI1240
The Low Density Lipoprotein Receptor-related Protein Complexes with Cell Surface Heparan Sulfate Proteoglycans to Regulate Proteoglycan-mediated Lipoprotein Catabolism, Journal of Biological Chemistry, vol.278, issue.18, pp.278-1575815764, 2003. ,
DOI : 10.1074/jbc.M208786200
Type 2 diabetes in mice induces hepatic overexpression of sulfatase 2, a novel factor that suppresses uptake of remnant lipoproteins, Hepatology, vol.27, issue.6, 2010. ,
DOI : 10.1002/hep.23916
Inhibition of hepatic sulfatase-2 In Vivo: A novel strategy to correct diabetic dyslipidemia, Hepatology, vol.114, issue.6, p.17461753, 2012. ,
DOI : 10.1002/hep.25580
Liver heparan sulfate proteoglycans mediate clearance of triglyceride-rich lipoproteins independently of LDL receptor family members, Journal of Clinical Investigation, vol.117, issue.1, p.153164, 2007. ,
DOI : 10.1172/JCI29154
Syndecan-1 is the primary heparan sulfate proteoglycan mediating hepatic clearance of triglyceride-rich lipoproteins in mice, Journal of Clinical Investigation, vol.119, p.32363245, 2009. ,
DOI : 10.1172/JCI38251DS1
Influence of the HDL Receptor SR-BI on Lipoprotein Metabolism and Atherosclerosis, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.23, issue.10, p.17321738, 2003. ,
DOI : 10.1161/01.ATV.0000091363.28501.84
Lipid-altering efficacy of ezetimibe plus statin and statin monotherapy and identification of factors associated with treatment response: A pooled analysis of over 21,000 subjects from 27 clinical trials, Atherosclerosis, vol.223, issue.2, p.251261, 2012. ,
DOI : 10.1016/j.atherosclerosis.2012.02.016
Virolytic action of lipoprotein lipase on hepatitis C virus in human sera, Medical Microbiology and Immunology, vol.191, issue.1, 1724. ,
DOI : 10.1007/s00430-001-0106-x
Lipoprotein lipase mediates hepatitis C virus (HCV) cell entry and inhibits HCV infection, Cellular Microbiology, vol.267, issue.10, p.24452456, 2007. ,
DOI : 10.1128/JVI.01307-06
Lipoprotein lipase and hepatic triglyceride lipase reduce the infectivity of hepatitis C virus (HCV) through their catalytic activities on HCV-associated lipoproteins, Virology, vol.407, issue.1, p.152159, 2010. ,
DOI : 10.1016/j.virol.2010.08.011
Lipoprotein Lipase Inhibits Hepatitis C Virus (HCV) Infection by Blocking Virus Cell Entry, PLoS ONE, vol.6, issue.10, p.26637, 2011. ,
DOI : 10.1371/journal.pone.0026637.s001
Very low-density lipoprotein/lipo-viro particles reverse lipoprotein lipase-mediated inhibition of hepatitis C virus infection via apolipoprotein C-III, Gut, vol.322, issue.Suppl, pp.10-1136, 2012. ,
DOI : 10.1136/gutjnl-2011-301798
Cellular Binding of Hepatitis C Virus Envelope Glycoprotein E2 Requires Cell Surface Heparan Sulfate, Journal of Biological Chemistry, vol.278, issue.42, pp.278-4100341012, 2003. ,
DOI : 10.1074/jbc.M302267200
Viral and cellular determinants of the hepatitis C virus envelope-heparan sulfate interaction, J. Virol, vol.80, 2006. ,
Hepatitis C Virus Attachment Mediated by Apolipoprotein E Binding to Cell Surface Heparan Sulfate, Journal of Virology, vol.86, issue.13, p.72567267, 2012. ,
DOI : 10.1128/JVI.07222-11
Initiation of hepatitis C virus infection is dependent on cholesterol and cooperativity between CD81 and scavenger receptor B type I. J. Viro, p.374383, 2007. ,
Transmembrane and cytoplasmic domains of syndecan mediate a multi-step endocytic pathway involving detergent-insoluble membrane rafts, Biochem. J, pp.351-607612, 2000. ,
The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus, The EMBO Journal, vol.269, issue.19, p.50175025, 2002. ,
DOI : 10.1093/emboj/cdf529
Scavenger receptor class B type I and hepatitis C virus infection of primary tupaia hepatocytes, J. Virol, pp.79-57745785, 2005. ,
Scavenger Receptor Class B Is Required for Hepatitis C Virus Uptake and Cross-Presentation by Human Dendritic Cells, Journal of Virology, vol.82, issue.7, p.34663479, 2008. ,
DOI : 10.1128/JVI.02478-07
Role of scavenger receptor class B type I in hepatitis C virus entry: Kinetics and molecular determinants, J. Virol, vol.84, p.3443, 2010. ,
URL : https://hal.archives-ouvertes.fr/inserm-00580589
Receptor Complementation and Mutagenesis Reveal SR-BI as an Essential
HCV Entry Factor and Functionally Imply Its Intra- and Extra-Cellular Domains, PLoS Pathogens, vol.100, issue.2, 2009. ,
DOI : 10.1371/journal.ppat.1000310.s005
High Density Lipoprotein Inhibits Hepatitis C Virus-neutralizing Antibodies by Stimulating Cell Entry via Activation of the Scavenger Receptor BI, Journal of Biological Chemistry, vol.281, issue.27, pp.281-1828518295, 2006. ,
DOI : 10.1074/jbc.M602706200
URL : https://hal.archives-ouvertes.fr/hal-00313930
et al. Neutralizing host responses in hepatitis C virus infection target viral entry at postbinding steps and membrane fusion, Gastroenterology, vol.135, p.17191728, 2008. ,
Opening the door for hepatitis C virus infection in genetically humanized mice, Hepatology, vol.207, issue.5, p.18731875, 2011. ,
DOI : 10.1002/hep.24603
URL : https://hal.archives-ouvertes.fr/inserm-00701498
Scavenger receptor class B type I is a key host factor for hepatitis C virus infection required for an entry step closely linked to CD81, Hepatology, vol.279, issue.6, p.17221731, 2007. ,
DOI : 10.1002/hep.21994
URL : https://hal.archives-ouvertes.fr/inserm-00395706
Increased HDL Cholesterol and ApoA-I in Humans and Mice Treated With a Novel SR-BI Inhibitor, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.29, issue.12, p.29, 2009. ,
DOI : 10.1161/ATVBAHA.109.191320
Small molecule scavenger receptor BI antagonists are potent HCV entry inhibitors, Journal of Hepatology, vol.54, issue.1, p.4855, 2011. ,
DOI : 10.1016/j.jhep.2010.06.024
Adenovirus-mediated hepatic overexpression of scavenger receptor class B type I accelerates chylomicron metabolism in C57BL/6J mice, The Journal of Lipid Research, vol.46, issue.6, pp.46-11721181, 2005. ,
DOI : 10.1194/jlr.M400361-JLR200
Scavenger receptor BI facilitates the metabolism of VLDL lipoproteins in vivo, The Journal of Lipid Research, vol.49, issue.1, pp.49-136146, 2008. ,
DOI : 10.1194/jlr.M700355-JLR200
Characterization of hepatitis C virus particle subpopulations reveals multiple usage of the scavenger receptor BI for entry steps, J. Biol. Chem, vol.287, p.3124231257, 2012. ,
URL : https://hal.archives-ouvertes.fr/hal-00965024
The post-binding activity of scavenger receptor BI mediates initiation of hepatitis C virus infection and viral dissemination, Hepatology, vol.57, p.492504, 2013. ,
A.; et al. Identification of the Niemann-Pick C1-like 1 cholesterol absorption receptor as a new hepatitis C virus entry factor, Nat. Med, vol.18, p.281285, 2012. ,
URL : https://hal.archives-ouvertes.fr/hal-00931582
Low pH-dependent Hepatitis C Virus Membrane Fusion Depends on E2 Integrity, Target Lipid Composition, and Density of Virus Particles, Journal of Biological Chemistry, vol.284, issue.26, p.1765717667, 2009. ,
DOI : 10.1074/jbc.M109.014647
Morphological Characterization and Fusion Properties of Triglyceride-rich Lipoproteins Obtained from Cells Transduced with Hepatitis C Virus Glycoproteins, Journal of Biological Chemistry, vol.285, issue.33, 2010. ,
DOI : 10.1074/jbc.M110.131664
et al. Ceramide enrichment of the plasma membrane induces CD81 internalization and inhibits hepatitis C virus entry, N Cell Microbiol, vol.10, p.606617, 2008. ,
The association of CD81 with tetraspanin-enriched microdomains is not essential for Hepatitis C virus entry, BMC Microbiology, vol.9, issue.1, p.111, 2009. ,
DOI : 10.1186/1471-2180-9-111
Lipoprotein Heterogeneity and Apolipoprotein B Metabolism, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.17, issue.12, pp.17-35423556, 1997. ,
DOI : 10.1161/01.ATV.17.12.3542
Structural requirements of virion-associated cholesterol for infectivity, buoyant density and apolipoprotein association of hepatitis C virus, Journal of General Virology, vol.92, issue.9, 2011. ,
DOI : 10.1099/vir.0.032391-0
Replication of Subgenomic Hepatitis C Virus RNAs in a Hepatoma Cell Line, Science, vol.285, issue.5424, p.110113, 1999. ,
DOI : 10.1126/science.285.5424.110
Characterization of the hepatitis C virus RNA replication complex associated with lipid rafts, Virology, vol.324, issue.2, p.450461, 2004. ,
DOI : 10.1016/j.virol.2004.03.034
Identification of FBL2 As a Geranylgeranylated Cellular Protein Required for Hepatitis C Virus RNA Replication, Molecular Cell, vol.18, issue.4, p.425434, 2005. ,
DOI : 10.1016/j.molcel.2005.04.004
Hepatitis C virus RNA replication is regulated by host geranylgeranylation and fatty acids, Proc. Natl. Acad. Sci. USA 2005, p.25612566 ,
DOI : 10.1073/pnas.0409834102
Enhancement of genotype 1 hepatitis C virus replication by bile acids through FXR, Journal of Hepatology, vol.48, issue.2, p.48, 2008. ,
DOI : 10.1016/j.jhep.2007.09.015
Bile Acids Specifically Increase Hepatitis C Virus RNA-Replication, PLoS ONE, vol.6, issue.4, p.36029, 2012. ,
DOI : 10.1371/journal.pone.0036029.s003
Three-Dimensional Architecture and Biogenesis of Membrane Structures Associated with Hepatitis C Virus Replication, PLoS Pathogens, vol.116, issue.12, p.1003056, 2012. ,
DOI : 10.1371/journal.ppat.1003056.s008
Efficient hepatitis C virus particle formation requires diacylglycerol acyltransferase-1, Nat. Med, vol.16, p.12951298, 2010. ,
TIP47 plays a crucial role in the life cycle of hepatitis C virus, J. Hepatol ,
The lipid droplet is an important organelle for hepatitis C virus production, Nature Cell Biology, vol.71, issue.9, p.10891097, 2007. ,
DOI : 10.1007/s00418-005-0061-5
Lipoprotein component associated with hepatitis C virus is essential for virus infectivity, Current Opinion in Virology, vol.1, issue.1, 1926. ,
DOI : 10.1016/j.coviro.2011.05.017
Hepatitis C Virus RNA Replication Occurs on a Detergent-Resistant Membrane That Cofractionates with Caveolin-2, Journal of Virology, vol.77, issue.7, pp.77-41604168, 2003. ,
DOI : 10.1128/JVI.77.7.4160-4168.2003
Self-Enhancement of Hepatitis C Virus Replication by Promotion of Specific Sphingolipid Biosynthesis, PLoS Pathogens, vol.8, issue.8, p.1002860, 2012. ,
DOI : 10.1371/journal.ppat.1002860.s013
Host sphingolipid biosynthesis as a target for hepatitis C virus therapy, Nat. Chem. Biol, vol.1, p.333337, 2005. ,
Sphingomyelin Activates Hepatitis C Virus RNA Polymerase in a Genotype-Specific Manner, Journal of Virology, vol.84, issue.22, p.1176111770, 2010. ,
DOI : 10.1128/JVI.00638-10
Recruitment and activation of a lipid kinase by hepatitis C virus NS5A is essential for integrity of the membranous replication compartment, Cell Host Microbe, vol.9, p.3245, 2011. ,
Essential metabolic, anti-inflammatory, and anti-tumorigenic functions of miR-122 in liver, Journal of Clinical Investigation, vol.122, issue.8, p.28712883, 2012. ,
DOI : 10.1172/JCI63539DS1
MicroRNA-122 plays a critical role in liver homeostasis and hepatocarcinogenesis, Journal of Clinical Investigation, vol.122, issue.8, p.28842897, 2012. ,
DOI : 10.1172/JCI63455DS1
Modulation of Hepatitis C Virus RNA Abundance by a Liver-Specific MicroRNA, Science, vol.309, issue.5740, p.15771581, 2005. ,
DOI : 10.1126/science.1113329
Stabilization of hepatitis C virus RNA by an Ago2-miR-122 complex, Proc. Natl. Acad. Sci. USA 2012, p.941946 ,
DOI : 10.1073/pnas.1112263109
Decreased levels of microRNA miR-122 in individuals with hepatitis C responding poorly to interferon therapy, Nature Medicine, vol.15, issue.1, p.3133, 2009. ,
DOI : 10.1136/gut.2007.128611
Honing, S. TIP47 functions in the biogenesis of lipid droplets, J. Cell Biol, pp.185-641655, 2009. ,
Lipid droplets: a unified view of a dynamic organelle, Nature Reviews Molecular Cell Biology, vol.13, issue.5, 2006. ,
DOI : 10.1038/nrm1912
Proteomic Profiling of Lipid Droplet Proteins in Hepatoma Cell Lines Expressing Hepatitis C Virus Core Protein, Journal of Biochemistry, vol.139, issue.5, p.921930, 2006. ,
DOI : 10.1093/jb/mvj104
Hepatitis C Virus Core Protein Induces Lipid Droplet Redistribution in a Microtubule- and Dynein-Dependent Manner, Traffic, vol.278, issue.8, p.12681282, 2008. ,
DOI : 10.1111/j.1600-0854.2008.00767.x
Disrupting the association of hepatitis C virus core protein with lipid droplets correlates with a loss in production of infectious virus, Journal of General Virology, vol.88, issue.8, p.22042213, 2007. ,
DOI : 10.1099/vir.0.82898-0
The Lipid Droplet Binding Domain of Hepatitis C Virus Core Protein Is a Major Determinant for Efficient Virus Assembly, Journal of Biological Chemistry, vol.282, issue.51, p.3715837169, 2007. ,
DOI : 10.1074/jbc.M707329200
URL : https://hal.archives-ouvertes.fr/hal-00315148
Maturation of Hepatitis C Virus Core Protein by Signal Peptide Peptidase Is Required for Virus Production, Journal of Biological Chemistry, vol.283, issue.24, p.1685016859, 2008. ,
DOI : 10.1074/jbc.M802273200
Triglyceride synthesis and hepatitis C virus production: Identification of a novel host factor as antiviral target, Hepatology, vol.50, issue.3, 2011. ,
DOI : 10.1002/hep.24177
Essential Role of Cyclophilin A for Hepatitis C Virus Replication and Virus Production and Possible Link to Polyprotein Cleavage Kinetics, PLoS Pathogens, vol.162, issue.8, p.1000546, 2009. ,
DOI : 10.1371/journal.ppat.1000546.s001
Inhibition of cyclophilins alters lipid trafficking and blocks hepatitis C virus secretion, Virology Journal, vol.8, issue.1, p.329, 2011. ,
DOI : 10.1038/nprot.2006.395
Human Subtilase SKI-1/S1P Is a Master Regulator of the HCV Lifecycle and a Potential Host Cell Target for Developing Indirect-Acting Antiviral Agents, PLoS Pathogens, vol.268, issue.Pt 7, p.1002468, 2012. ,
DOI : 10.1371/journal.ppat.1002468.s006
Hepatitis C virus production by human hepatocytes dependent on assembly and secretion of very low-density lipoproteins, Proc. Natl. Acad. Sci, p.58485853, 2007. ,
DOI : 10.1073/pnas.0700760104
Hepatitis C virus core protein inhibits microsomal triglyceride transfer protein activity and very low density lipoprotein secretion: a model of viral-related steatosis, The FASEB Journal, vol.16, issue.2, p.185194, 2002. ,
DOI : 10.1096/fj.01-0396com
Hillon, P. Hepatitis C virus-associated hypobetalipoproteinemia is correlated with plasma viral load, steatosis, and liver fibrosis, Am. J. Gastroenterol, pp.98-11501154, 2003. ,
Apolipoprotein E but not B is required for the formation of infectious hepatitis C virus particles, J. Virol, vol.83, p.1268012691, 2009. ,
Lipoprotein profiles in SCID/uPA mice transplanted with human hepatocytes become human-like and correlate with HCV infection success, AJP: Gastrointestinal and Liver Physiology, vol.299, issue.4, pp.299-844, 2010. ,
DOI : 10.1152/ajpgi.00200.2010
Molecular Determinants and Dynamics of Hepatitis C Virus Secretion, PLoS Pathogens, vol.131, issue.Pt 13, p.1002466, 2012. ,
DOI : 10.1371/journal.ppat.1002466.s030
Role of Oxysterol Binding Protein in Hepatitis C Virus infection, Journal of Virology, vol.83, issue.18, p.92379246, 2009. ,
DOI : 10.1128/JVI.00958-09
Protein Kinase D Negatively Regulates Hepatitis C Virus Secretion through Phosphorylation of Oxysterol-binding Protein and Ceramide Transfer Protein, Journal of Biological Chemistry, vol.286, issue.13, p.1126511274, 2011. ,
DOI : 10.1074/jbc.M110.182097
Metabolomic Profile of Hepatitis C Virus-Infected Hepatocytes, PLoS ONE, vol.42, issue.8, 2011. ,
DOI : 10.1371/journal.pone.0023641.s002